⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Fostamatinib (SYK Inhibition)
Current understanding
To be populated as evidence accumulates.
Evidence log
Open questions
Related
Contributing findings
Identification of senescence-related genes in Parkinson's disease reveals candidate therapeutic targets and pathological processes.
30-jun-2026
novelty 2
per-area 2
introduces